Beaumont Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Beaumont Asset Management's PFE Position: Q2 2025 in Review
Beaumont Asset Management sold out of Pfizer (PFE) in Q2 2025, closing a stake of 17,517 shares — an estimated $444K sold.
Beaumont Asset Management first reported a position in PFE in Q4 2019 and held it in 21 quarters. The position peaked at $1.54M in Q4 2021. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.
- Beaumont Asset Management reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
- Beaumont Asset Management sold 17,517 Pfizer shares in Q2 2025, an estimated $444K.
- Beaumont Asset Management first reported a position in Pfizer in Q4 2019 and held it in 21 quarters.
- Beaumont Asset Management's Pfizer position peaked at $1.54M in Q4 2021.
- 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.
Based on Beaumont Asset Management's 13F filing for Q2 2025, filed 23 Jul 2025.